Epidemiology and Histology Aspects of Breast Cancers of Women in Ivory Coast


Breast cancer is a major public health problem both in developed countries, where it represents the first female cancer, and in developing countries, where its incidence is increasing. Purpose: The authors report the results of a study whose objective was to describe the epidemiological and pathological features of women’s breast cancers in Ivory Coast. Material and Methods: This is a retrospective descriptive study on breast cancer histologically confirmed and made from the records of pathology laboratories of the University Hospital in Abidjan. The study period was 24 years (1984-2007). The parameters studied were: frequency, age, risk factors, the macroscopic and histological aspects. Results: Women’s breast cancer was the second cancer among women (13.69%) after cervical cancer and represented 6.51% of cancers. The average age was 45.21 years ranging from 10 years to 85 years. Subjects from 35 to 44 years were the most affected (30.7%) and 8% of patients were under 30 years (n=61). Multiparity (53.55%) and lower socioeconomic level (79.63%) were associated. At the macroscopic level nodular aspects represented 47.62% of cases (n=301). Carcinomas were 92% (n=710) of histological types with 94.36% (n=692) of invasive carcinomas. Sarcomas (5.7%), lymphoma (2.1%) and Paget’s disease (0.3%) were also observed. With regard to prognostic, the grading of Scarff-Bloom and Richardson showed 26.75% (n=156) grade I, 60.64% (n=354) grade II and 12.52% (n=73%) grade III. Conclusion: In consideration of prognosis of advanced forms, an effort should be made for diagnosis and early treatment of women’s breast cancer in Ivory Coast.

Share and Cite:

J. N’Dah Kouame, E. Troh, E. Koffi Kouakou, B. Doukouré, A. Didier Kouame, A. Didier Abouna, B. Ahoua Effi and M. I Diomandé, "Epidemiology and Histology Aspects of Breast Cancers of Women in Ivory Coast," Journal of Cancer Therapy, Vol. 3 No. 5A, 2012, pp. 782-786. doi: 10.4236/jct.2012.325098.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] World Health Organization (WHO 2008), “The Global Burden of Disease,” 2004 Update.
[2] H. Rochefort and J. Rou?ssé, “Breast Cancer: Incidence and Prevention,” Report of a Working Group of Committee III (Cancer), 2000, p. 22.
[3] I. Diomandé, A. F. D’Horpock, P. Heroin, M. Ette, A. Dago, F. Battesti, et al., “EVol.ution of Cancer in Ivory Coast,” Medical Publication in Ivory Coast, Vol. 75, 1988, pp. 81-84.
[4] A. Echimane, A. Ahnoux, I. Adoubi, S. Hien, K. M’Bra, A. F. D’Horpock, et al., “Cancer Incidence in Abidjan, Ivory Coast. First Results from the Cancer Registry, 1995-1997,” Cancer, Vol. 89, No. 3, 2000, pp. 653-663. doi:10.1002/1097-0142(20000801)89:3<653::AID-CNCR22>3.0.CO;2-Z
[5] M. Traore, F. S. Diabate, I. Diarra, N. Mounkoro, Y. Traore, I. Tekété, et al., “Breast and Gynecologic Cancer at the Hospital from the Point G in Bamako,” Medical Publication in Mali, Vol. 19, No. 2, 2004, pp. 4-9.
[6] D. Sano, R. Cissé, B. Dao, J. Lankoandé, S. S. Traore, R. B. Soudré, et al., “Breast Cancer, Diagnostic and Therapeutic Problems at the Hospital of Ouagadougou,” Medical Publication in Subsaharan Africa, Vol. 45, No. 5, 1998, pp. 297-301.
[7] H. Najjar and A. Easson, “Age at Diagnosis of Breast Cancer in Arab Nations,” International Journal of Surgery, 2010, [Epub ahead of print].
[8] C. R. Raharisolo Vol.olonantenaina, L. P. Rabarijiaona, C. Rajemiarimoeisoa, M. Rasendramino and R. Migliani, “Assessment of Breast Cancers Diagnosed L’institut Pasteur de Madagascar from 1995 to 2001,” Archives de L’Institut Pasteur de Madagascar, Vol. 68, 2002, pp. 104-108.
[9] D. Shaheenah, B. Kristine, A. Gonzalez, A. U. Busdor, N. Hortobagyi and H. G. Sharon, “Trends in Survival over the Past Two Decades among White in Black Patients with Newly Diagnosed Internship IV Breast Cancer,” Journal of Clinical Oncology, Vol. 26, 30, 2008, pp. 4889-4899.
[10] C. A. Adebamowo, S. N. Akarolo-Anthony and O. O. Temiayo, “Emerging Epidermic Breast Cancer: Evidence from Africa,” Breast Cancer Research, Vol. 12, Supp. l 4, 2010, S8. doi:10.1186/bcr2737
[11] A. Antoniou, P. D. Pharoah, S. Narod, H. A. Risch, J. E. Eyfjord, J. L. Hopper, et al., “Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies,” Erratum in: The American Journal of Human Genetics, Vol. 73, No. 3, 2003, p. 709.
[12] C. M. Friedenreich and M. R. Orenstein, “Physical Activity and Cancer Prevention: Etiologic Evidence and Biological Mechanisms,” Journal of Nutrition, Vol. 132, No. 11, 2002, 3456S-3664S.
[13] World Health Organization, “Tumors of the Breast and the Female Genital Organs,” In: P. Deviled, Ed., Pathology and Genetics, IARC Press, Lyon, 2003, pp. 13-59.
[14] A. Laplanche and E. Benhamou, “Estimated incidence of Cancer in France,” Bull Cancer, Vol. 78, No. 5, 1991, pp. 505-514.
[15] E. Duarte-Franco and E. L. Franco, “Others Gynecologic Cancers: Endometrial, Ovarian, and Vaginal Cancers Vulva,” BMC Women’s Health, Vol. 25, Suppl. 1, 2004, p. S14. doi:10.1186/1472-6874-4-S1-S14
[16] D. M. Parkin, S. L. Whelan, J. Ferlay, L. Raymond and J. Young, “Cancer in Five Continents,” IARC Scientific Publications, Lyon, Vol. 12, No. 143, 1997, pp. 35-36.
[17] A. B. Effi, K. J. N’Dah, A. A. N’Guiessan, B. Doukouré, M. Kouyaté, A. D. Abouna, et al., “Epidemiology and Pathology of Carcinoma in Ivory Coast,” African Journal of Cancer, Vol. 4, 2012, pp. 41-47. doi:10.1007/s12558-011-0189-2

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.